10x Genomics (TXG) Earnings Date, Estimates & Call Transcripts $22.08 +0.67 (+3.13%) (As of 09/18/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 7EstimatedActual EPS (Aug. 8) -$0.32 Beat By $0.15 Consensus EPS (Aug. 8) -$0.47 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTXG Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TXG Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIMassive shakeup in defense contractingThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.You need to check out the full story right here. 10x Genomics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ2 20241($0.53)($0.53)($0.53) Q3 20242($0.41)($0.27)($0.34) Q4 20242($0.30)($0.15)($0.23) 20245($1.24)($0.95)($1.10) Q1 20251($0.29)($0.29)($0.29) Q2 20251($0.22)($0.22)($0.22) Q3 20251($0.16)($0.16)($0.16) Q4 20251($0.02)($0.02)($0.02) FY 20254($0.69)($0.69) ($0.69)TXG Earnings Date and Information10x Genomics last posted its earnings results on August 8th, 2024. The reported ($0.32) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.47) by $0.15. The company had revenue of $153.10 million for the quarter, compared to analysts' expectations of $150.90 million. 10x Genomics has generated ($2.23) earnings per share over the last year (($2.23) diluted earnings per share). Earnings for 10x Genomics are expected to grow in the coming year, from ($1.32) to ($0.87) per share. 10x Genomics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off prior year's report dates.Read More 10x Genomics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/7/2024(Estimated)------- 8/8/2024Q2 2024($0.47)($0.32)+$0.15($0.32)$150.90 million$153.10 million4/30/2024Q1 2024($0.50)($0.50)-($0.50)$142.24 million$141.01 million 2/15/2024Q4 2023($0.36)($0.41)($0.05)($0.41)$182.73 million$183.98 million 11/2/2023Q3 2023($0.45)($0.51)($0.06)($0.23)$150.11 million$153.64 million 8/3/2023Q2 2023($0.39)($0.53)($0.14)($0.53)$139.97 million$146.82 million 5/3/2023Q1 2023($0.38)($0.44)($0.06)($0.44)$128.87 million$134.29 million Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late.2/15/2023Q4 2022($0.29)($0.15)+$0.14($0.15)$148.17 million$156.20 million 11/2/2022Q3 2022($0.45)($0.37)+$0.08($0.37)$129.13 million$131.10 million 8/8/2022Q2 2022($0.40)($0.57)($0.17)($0.57)$115.89 million$114.61 million 5/4/2022Q1 2022($0.37)($0.38)($0.01)($0.38)$113.33 million$114.50 million 2/16/2022Q4 2021($0.06)($0.16)($0.10)($0.16)$148.50 million$143.53 million 11/3/2021Q3 2021($0.18)($0.15)+$0.03($0.15)$124.07 million$125.30 million 8/3/2021Q2 2021($0.26)($0.10)+$0.16($0.10)$112.85 million$115.84 million 5/4/2021Q1 2021($0.27)($0.11)+$0.16($0.11)$102.75 million$105.82 million 2/16/2021Q4 2020($0.28)($3.87)($3.59)$3.71$101.20 million$112.22 million 11/15/2020Q3 2020($0.30)($0.65)($0.35)($0.01)$61.19 million$71.82 million 11/10/2020Q3 2020($0.33)($0.33)-($0.01)$62.71 million$71.82 million 8/11/2020Q2 2020($0.59)($0.41)+$0.18($0.41)$29.07 million$42.91 million8/11/2020Q2 2020($0.59)($0.41)+$0.18($0.41)$30.58 million$42.90 million 5/11/2020Q1 2020($0.20)($0.22)($0.02)($0.22)$71.50 million$71.91 million5/11/2020Q1 2020($0.13)($0.22)($0.09)($0.22)$71.67 million$71.91 million 2/18/2020Q4 2019($0.15)($0.07)+$0.08($0.07)$69.71 million$75.29 million2/18/2020Q4($0.11)($0.07)+$0.04($0.07)$70.00 million$75.29 million 11/7/2019Q3 2019($0.13)($0.33)($0.20)($0.33)$54.33 million$61.21 million11/7/2019Q3($0.13)($0.33)($0.20)($0.33)$54.33 million$61.21 million 10x Genomics Earnings - Frequently Asked Questions When is 10x Genomics's earnings date? 10x Genomics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates. Learn more on TXG's earnings history. What guidance has 10x Genomics issued on next quarter's earnings? 10x Genomics issued an update on its FY 2024 earnings guidance on Thursday, August, 8th. The company issued revenue guidance of $640.0 million-$660.0 million, compared to the consensus revenue estimate of $663.1 million. Did 10x Genomics beat their earnings estimates last quarter? In the previous quarter, 10x Genomics (NASDAQ:TXG) reported ($0.32) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.47) by $0.15. Learn more on analysts' earnings estimate vs. TXG's actual earnings. How much revenue does 10x Genomics generate each year? 10x Genomics (NASDAQ:TXG) has a recorded annual revenue of $618.73 million. How much profit does 10x Genomics generate each year? 10x Genomics (NASDAQ:TXG) has a recorded net income of -$255.10 million. TXG has generated -$2.23 earnings per share over the last four quarters. What is 10x Genomics's EPS forecast for next year? 10x Genomics's earnings are expected to grow from ($1.32) per share to ($0.87) per share in the next year. More Earnings Resources from MarketBeat Related Companies: BRKR Earnings Results BIO.B Earnings Results BIO Earnings Results OLK Earnings Results LAB Earnings Results CTKB Earnings Results QTRX Earnings Results PACB Earnings Results EYPT Earnings Results NAUT Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:TXG) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredKamala Harris To Tank the Market?URGENT ELECTION MELTDOWN WARNING From the former CIA advisor who predicted President Trump’s win in 2016…Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding 10x Genomics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXG Stock Alerts